The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (11 analysts) rates it buy, with a mean price target of $106.
Coca-Cola Europacific Partners Plc
CCEP · NASDAQ · USD · Market cap $45.8B · 37,003 employees
Coca-Cola Europacific Partners PLC, together with its subsidiaries, produces, distributes, and sells a range of non-alcoholic ready-to-drink beverages.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Coca-Cola Europacific Partners Plc holds its Distribution at $103.82. The statistical read favours the buyers, held for 21 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 21 days |
| Price at the screen | $103.82 |
| Valuation | 20.12 trailing · 18.20 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.48 |
Five Screens, Shown in Full
Does not pass. Excluded keyword in: Beverages - Non-Alcoholic
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Excluded keyword in: Beverages - Non-Alcoholic | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. The price runs 2.0% above the base estimate.
Third-party analyst targets: 12 covering, consensus Buy. The average target sits +11% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCoca-Cola Bottler Trips Ethical Screen First
Grab a can from the fridge in any European city and the odds are high it travelled through this bottler's network. The operation delivers steady nine per cent margins and twenty-three per cent returns on equity while the shares sit right on our fair value with no margin of safety.
Yet the ethical screen stops us cold. The non-alcoholic beverages category itself triggers an outright fail, so the narrow moat, flat revenue and eighteen-point-eight times forward earnings never get a proper look in.
Zero growth leaves little cushion if volumes soften, and the modest premium to fair value offers no reward for the category exclusion. Consensus targets sit only a touch higher and do not move the needle.
Analysis, not advice.
| Forward P/E | 18.2xexpensive even after accounting for its growth |
| Trailing P/E | 20.1xa premium valuation |
| EPS, trailing | 5.16 |
| EPS, forward | 5.70 |
| Revenue growth | +4.4%slow but positive growth |
| Profit margin | 9.3%thin but positive margins |
| Return on equity | 23.5%an exceptional return on shareholder capital |
| FCF yield | 3.46% |
| Dividend yield | 242.00% |
| Debt to equity | 1.39a meaningful debt load worth watching |
| Current ratio | 0.89below 1: short-term bills exceed liquid assets |
| Beta | 0.48barely tracks the market's swings |
| Short interest, float | 0.07% |
| 52-week range | 84.66 - 113.67 |
| Moat | NARROW |
| Market cap | $45.8B |
| Employees | 37,003 |
The risks · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCCEP trades on NASDAQ (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (11 analysts) rates it buy, with a mean price target of $106.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (11 analysts) rates it buy, with a mean price target of $106.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Coca-Cola Europacific Partners PLC (CCEP): A Top UK Growth Dividend Stock to Consider on Robust Growth Expectations Insider Monkey · 16 Jul 2026
- KDP or CCEP: Which Is the Better Value Stock Right Now? Zacks · 23 Jun 2026
- Uber, Autodesk, Coca-Cola, Levi Strauss and Others Call for Governments to Accelerate Electrification MT Newswires · 22 Jun 2026
- Coca-Cola’s America250 Push Highlights Packaging Rewards And Plastic Risks Simply Wall St. · 29 May 2026
- A Look At Coca-Cola Europacific Partners (ENXTAM:CCEP) Valuation After Recent Share Price Weakness Simply Wall St. · 27 May 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $92.46 | +5.3% | $0.96 | $1,064 | +6.4% |
| 2 months | $96.40 | +1.0% | $0.96 | $1,020 | +2.0% |
| 3 months | $100.16 | -2.8% | $0.96 | $982 | -1.8% |
| 6 months | $88.19 | +10.4% | $0.96 | $1,115 | +11.5% |
| 1 year | $90.47 | +7.6% | $2.39 | $1,103 | +10.3% |
| 2 years | $70.42 | +38.3% | $4.63 | $1,449 | +44.9% |
| 3 years | $58.55 | +66.3% | $6.65 | $1,777 | +77.7% |
| 5 years | $52.82 | +84.4% | $10.71 | $2,046 | +104.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CCEP does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.